Statistical Tutorial for Cut‐Point Determination in Immunogenicity Studies.
- Published in:
- Pharmaceutical Statistics, 2025, v. 24, n. 3, p. 1, doi. 10.1002/pst.70016
- By:
- Publication type:
- Article
Works matching IS 15391604 AND DT 2025 AND VI 24 AND IP 3
Results: 12
1
2
Why "Minimal Clinically Important Difference" for Interpreting the Magnitude of the Treatment Effect Is Not Useful.
- Published in:
- Pharmaceutical Statistics, 2025, v. 24, n. 3, p. 1, doi. 10.1002/pst.70015
- By:
- Publication type:
- Article
3
Chauhan Weighted Trajectory Analysis of Combined Efficacy and Safety Outcomes for Risk–Benefit Analysis.
- Published in:
- Pharmaceutical Statistics, 2025, v. 24, n. 3, p. 1, doi. 10.1002/pst.70014
- By:
- Publication type:
- Article
4
Detection of Outlying Correlation Coefficients in Multicenter Clinical Trials.
- Published in:
- Pharmaceutical Statistics, 2025, v. 24, n. 3, p. 1, doi. 10.1002/pst.70013
- By:
- Publication type:
- Article
5
The Choice Between Pearson's χ2 Test and Fisher's Exact Test for 2 × 2 Tables.
- Published in:
- Pharmaceutical Statistics, 2025, v. 24, n. 3, p. 1, doi. 10.1002/pst.70012
- By:
- Publication type:
- Article
6
Control of Unconditional Type I Error in Clinical Trials With External Control Borrowing—A Two‐Stage Adaptive Design Perspective.
- Published in:
- Pharmaceutical Statistics, 2025, v. 24, n. 3, p. 1, doi. 10.1002/pst.70011
- By:
- Publication type:
- Article
7
Multiple Comparisons Procedures for Analyses of Joint Primary Endpoints and Secondary Endpoints.
- Published in:
- Pharmaceutical Statistics, 2025, v. 24, n. 3, p. 1, doi. 10.1002/pst.70010
- By:
- Publication type:
- Article
8
Applying the Principal Stratum Strategy in Equivalence Trials: A Case Study.
- Published in:
- Pharmaceutical Statistics, 2025, v. 24, n. 3, p. 1, doi. 10.1002/pst.70008
- By:
- Publication type:
- Article
9
CUSUMIN Combination: A Cumulative Sum Interval Design for Phase I Cancer Drug‐Combination Trials.
- Published in:
- Pharmaceutical Statistics, 2025, v. 24, n. 3, p. 1, doi. 10.1002/pst.70007
- By:
- Publication type:
- Article
10
Randomization in Pre‐Clinical Studies: When Evolution Theory Meets Statistics.
- Published in:
- Pharmaceutical Statistics, 2025, v. 24, n. 3, p. 1, doi. 10.1002/pst.70005
- By:
- Publication type:
- Article
11
A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions.
- Published in:
- Pharmaceutical Statistics, 2025, v. 24, n. 3, p. 1, doi. 10.1002/pst.70002
- By:
- Publication type:
- Article
12
Issue Information.
- Published in:
- Pharmaceutical Statistics, 2025, v. 24, n. 3, p. 1, doi. 10.1002/pst.2402
- Publication type:
- Article